Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03536884
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 743
Large-scale testing (Phase 3)Study completedNCT06586112
What this trial is testing

Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 912
Large-scale testing (Phase 3)Study completedNCT02489227
What this trial is testing

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coherus Oncology, Inc. 545
Testing effectiveness (Phase 2)Study completedNCT00557739
What this trial is testing

Study of CRx-191 to Assess Activity in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Zalicus 20
Large-scale testing (Phase 3)Study completedNCT03219437
What this trial is testing

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 104
Large-scale testing (Phase 3)Study completedNCT07712731
What this trial is testing

HPP737 in Adult Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Newsoara Biopharma Co., Ltd. 607
Large-scale testing (Phase 3)Looking for participantsNCT07511647
What this trial is testing

Clinical Study of QL2106 Injection

Who this might be right for
Plaque Psoriasis
Qilu Pharmaceutical Co., Ltd. 318
Large-scale testing (Phase 3)Active Not RecruitingNCT06143878
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 774
Large-scale testing (Phase 3)Study completedNCT02694523
What this trial is testing

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 684
Post-approval studies (Phase 4)Study completedNCT05510063
What this trial is testing

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Samsung Bioepis Co., Ltd. 371
Large-scale testing (Phase 3)Study completedNCT02559622
What this trial is testing

Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 151
Testing effectiveness (Phase 2)Study completedNCT02494479
What this trial is testing

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Cellceutix Corporation 115
Testing effectiveness (Phase 2)Study completedNCT01001468
What this trial is testing

Study to Assess VB-201 in Patients With Psoriasis

Who this might be right for
Active Plaque Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Large-scale testing (Phase 3)Active Not RecruitingNCT03997786
What this trial is testing

Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Sun Pharmaceutical Industries Limited 135
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Testing effectiveness (Phase 2)Study completedNCT01119339
What this trial is testing

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Who this might be right for
Psoriasis
Almirall, S.A. 20
Testing effectiveness (Phase 2)Study completedNCT00796211
What this trial is testing

A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Zalicus 20
Early research (Phase 1)Study completedNCT02193815
What this trial is testing

A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Pfizer 15
Testing effectiveness (Phase 2)Study completedNCT02776033
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

Who this might be right for
Psoriasis
GlaxoSmithKline 65
Large-scale testing (Phase 3)Looking for participantsNCT07326813
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 477
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation